Oak Street Health (OSH)
NYSE:OSH

Oak Street Health Stock Analysis & Ratings

Oak Street Health Stock Analysis Overview

Smart Score
7
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Oak Street Health stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

OSH

OSH Stock Stats

Previous Close$19.5
Open$19.91
Bid19 x 3
Ask41 x 1
Today’s Range$19.05 - $20.52
52-Week Range$19.05 - $66.31
Volume4.50M
Average Volume2.03M
Market Cap$4.61B
Beta1.15
P/E Ratio-11.8
EPS-1.62
Earnings DateMar 08, 2022

Company Description

Oak Street Health

Oak Street Health Inc is a fast-growing network of value-based, primary care centers for adults on Medicare. The company operates an healthcare model focused on quality of care over volume of services, and assumes the full financial risk of its patients. Oak Street Health operates more than 50 centers across Illinois, Michigan, Indiana, Pennsylvania, Ohio, Rhode Island, North Carolina and Tennessee, with plans to continue its geographic expansion, including into Texas and New York.
Sector
Healthcare
Industry
Healthcare Providers & Services
CEO
Mike Pykosz
Employees
4,000
Website
www.oakstreethealth.com
ISIN
US67181A1079
Address
30 W. Monroe Street, Chicago, IL, 60603, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

OSH FAQ

What was Oak Street Health’s price range in the past 12 months?
Oak Street Health lowest stock price was $19.05 and its highest was $66.31 in the past 12 months.
    What is Oak Street Health’s market cap?
    Oak Street Health’s market cap is $4.61B.
      What is Oak Street Health’s price target?
      The average price target for Oak Street Health is $42.82. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $63.00 ,the lowest forecast is $25.00. The average price target represents 123.95% Increase from the current price of $19.12.
        What do analysts say about Oak Street Health?
        Oak Street Health’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
          When is Oak Street Health’s upcoming earnings report date?
          Oak Street Health’s upcoming earnings report date is Mar 08, 2022 which is in 46 days.
            How were Oak Street Health’s earnings last quarter?
            Oak Street Health released its earnings results on Nov 08, 2021. The company reported -$0.49 earnings per share for the quarter, missing the consensus estimate of -$0.423 by -$0.067.
              Is Oak Street Health overvalued?
              According to Wall Street analysts Oak Street Health’s price is currently Undervalued.
                Does Oak Street Health pay dividends?
                Oak Street Health does not currently pay dividends.
                What is Oak Street Health’s EPS estimate?
                Oak Street Health’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Oak Street Health have?
                Oak Street Health has 240,930,000 shares outstanding.
                  What happened to Oak Street Health’s price movement after its last earnings report?
                  Oak Street Health reported an EPS of -$0.49 in its last earnings report, missing expectations of -$0.423. Following the earnings report the stock price went down -17.043%.
                    Which hedge fund is a major shareholder of Oak Street Health?
                    Among the largest hedge funds holding Oak Street Health’s share is Route One Investment Company. It holds Oak Street Health’s shares valued at 95M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis